Top pharmaceutical employers for Regulatory Affairs in China
Novartis is the pharmaceutical employer AI recommends most for Regulatory Affairs jobs in China, named in 90% of answers. Pfizer and Roche follow.
- 1Novartis#1 for Regulatory Affairs
- 1Pfizer#1 for Regulatory Affairs
- 1Roche#1 for Regulatory Affairs
- 4Sanofi
- 5AstraZeneca
- 6Bayer
- 7GSK
- 8Johnson & Johnson
- 9Jiangsu Hengrui Pharmaceuticals
- 9Merck & Co.
Hiring for Regulatory Affairs in China?
This page shows how often AI recommends you for this role. PerceptionX shows why it picks your rivals, and what to change so it picks you.
Questions about this ranking
Which pharmaceutical companies does AI recommend for Regulatory Affairs jobs in China?
Novartis. It comes up in 90% of answers when candidates ask AI about Regulatory Affairs jobs in Chinese pharmaceutical. Pfizer, Roche, Sanofi and AstraZeneca follow.
Is Novartis the top pick for every pharmaceutical role in China?
No. Novartis leads for Regulatory Affairs, and other roles in Chinese pharmaceutical have a different first pick. Each role has its own ranking.
What does the percentage mean?
It is the share of AI answers that name the employer when candidates ask about Regulatory Affairs jobs in Chinese pharmaceutical.
How is this ranking made?
We ask AI the questions candidates ask about Regulatory Affairs jobs in Chinese pharmaceutical, from pay to interviews, and measure how often each employer is recommended.
Do I need to be a PerceptionX customer to appear here?
No. Any employer AI recommends often enough appears automatically.